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Copyright © 2009 JCBN Summary Effects of soy isoflavones, genistein and daidzein, on the hepatic gene expression
profile and indices for lipid metabolism were compared in rats. In the first experiment
(Expt. 1), animals were fed diets containing 2 g/kg of either genistein or daidzein, or a control
diet free of isoflavone for 14 days. In the second experiment (Expt. 2), rats were fed diets
containing 1 or 2 g/kg of genistein, or an isoflavone-free diet for 16 days. Genistein at a dietary
level of 2 g/kg reduced serum triacylglycerol concentrations in both experiments, and serum
concentrations of cholesterol in Expt. 2. However, daidzein at 2 g/kg did not decrease serum
lipid concentrations in Expt. 1. A DNA microarray analysis in Expt. 1 showed that genistein
was stronger than daidzein in affecting gene expression in liver, targeting many genes involved
in lipid and carbohydrate metabolism. Detailed analyses indicated that alterations in the
expression of genes related to lipogenesis are primarily responsible for the serum lipid-
lowering effect of genistein. This notion was supported by analyses of the activity of enzymes
involved in lipogenesis in Expt. 2.
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Introduction
Dietary soy protein lowers blood lipid concentrations and
reduces the incidence of cardiovascular diseases in animals
and humans [1]. The soy protein preparations employed in
previous studies usually contained considerable amounts of
isoflavones, saponins, fiber, and phytic acid [2]. These extra
compound(s) may be partly responsible for the lipid-lowering
effect. Studies [3–10] indicate that soy isoflavones have the
physiological effect of lowering blood lipid levels. We
previously showed that serum triacylglycerol concentrations
were comparable between rats fed casein and rats fed a
methanol-washed soy protein preparation low in isoflavones;
however, supplementation of the soy protein preparation
with isoflavones dose-dependently decreased this parameter
[10]. Also, some studies [6–9] showed that soy isoflavones
added to an experimental diet containing casein as a protein
source reduced cholesterol and triacylglycerol concentra-
tions in the serum and/or liver of rodents. With regard to the
mechanism underlying the hypolipidemic effect of isofla-
vones, studies have indicated that isoflavones affected the
activity of enzymes involved in lipid metabolism [6, 9] and
mRNA levels of proteins related to β-oxidation and energy
metabolism in the liver of animals [5, 7]. These observations
suggest that dietary isoflavone plays a crucial role in regu-
lating lipid metabolism.
Genistin and daidzin are isoflavones abundant in soybean,
and their aglycones, genistein and daidzein, are released by
the action of intestinal glucosidase and absorbed from the
gastrointestinal tract [11]. It has been reported that genistein
is stronger than daidzein in its agonistic activity for theY. Takahashi et al.
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estrogen receptors [12]. Meanwhile, daidzein is metabolized
by enterobacteria to produce equol which has stronger estro-
genic and antioxidative activities than daidzein or the other
isoflavone metabolites [11, 12]. Therefore, it is plausible that
dietary daidzein and genistein influence lipid metabolism
differently. However, information on this topic is lacking.
Here we compared the physiological activity of dietary
genistein and daidzein in affecting the mRNA expression of
proteins involved in lipid metabolism in rat liver using a
DNA microarray technique.
Materials and Methods
Animals
This study was approved by the review board of animal
ethics in our institute, and we followed the institute’s
guidelines for the care and use of laboratory animals. Male
Sprague-Dawley rats purchased from Charles River Japan
(Kanagawa, Japan) at 4 weeks of age were housed indi-
vidually in a room with controlled temperature (20–22°C),
humidity (55–65%), and lighting (0700–1900 h), and fed a
commercial diet (Type NMF; Oriental Yeast, Tokyo, Japan).
Animals had free access to the diets and water during the
acclimatization and experimental periods. After 5 days of
acclimatization to the conditions, rats were randomly divided
into experimental groups with similar mean body weights
consisting of 7 animals each. In the first experiment (Expt.
1), 3 groups of rats were fed an experimental diet containing
2 g/kg of either genistein (LC Laboratories, Woburn, MA) or
daidzein (LC Laboratories), or a control diet free of isofla-
vone for 14 days. In the second trial (Expt. 2), 3 groups of
rats were fed diets containing 0, 1.0, or 2.0 g/kg of genistein
for 16 days. The basal composition of the experimental diet
was (in g/kg): casein, 200; palm oil, 100; corn starch, 150;
cellulose, 20; mineral mixture (AIN-93G, Oriental Yeast),
35; vitamin mixture (AIN-93, Oriental Yeast), 10; L-cystine,
3.0; choline bitartrate, 2.0 and sucrose to 1 kg. Genistein or
daidzein was added to the experimental diets instead of
sucrose. At the end of the experimental period, the animals
were killed by bleeding from the abdominal aorta under
diethyl ether anesthesia after 3 h of fasting.
Analyses of serum lipid and isoflavone concentrations
Serum triacylglycerol, cholesterol, phospholipid, and free
fatty acid concentrations were analyzed using commercial
enzyme kits (Wako Pure Chemical Industries, Osaka, Japan).
Serum isoflavone concentrations were analyzed by HPLC
as detailed previously [10].
Microarray analysis
RNA extracted from the livers of 5 rats from each group
was subjected to microarray analyses (Expt. 1). The selec-
tion was based on serum triacylglycerol levels. Those rats
with the highest and lowest values for this parameter were
eliminated from the microarray analyses. Hepatic RNA was
extracted and purified using the RNeasy Mini Kit (Qiagen,
Valencia, CA). Total RNA (10 μg) purified from each
sample was processed to prepare biotin-labeled cRNA
using One-Cycle Target Labeling and Control Reagents
(Affymetrix, Santa Clara, CA). cRNA was fragmented and
used as a probe for hybridization to the Affymetrix Rat
Genome 230_2.0 GeneChip microarray. After the washing
and staining processes, the arrays were scanned with a GCS
3000 scanner (Affymetrix) and analyzed by Affymetrix
GeneChip Operating Software 1.2 (GCOS). Subsequent
analyses of microarray data were carried out using
GeneSpring 7.3.1 software (Agilent Technologies, Santa
Clara, CA). Per chip and per gene normalizations were
carried out using a 50 percentile value of signal intensity in
each chip, and the mean values in the group of rats fed a
control diet free of isoflavone, respectively. After the
normalizations, unreliable data with low signal intensity
were eliminated: data had to fulfill the following criteria.
First, the average raw signal intensity should be greater
than 50 in at least 2 of 3 dietary treatments. Second, the
expression data should call present- or marginal-flags
according to the GCOS algorithm in more than 5 of 15
arrays. After the filtering process, the expression data for
9,307 of 31,099 transcripts survived, and the lists were
further analyzed to clarify the genes whose expression was
significantly (p<0.05) affected more than 1.5-fold by dietary
isoflavones. The functions of genes were clarified using
several data-bases including the Rat Genome Database
(http://rgd.mcw.edu/), KEGG (http://www.kegg.jp/kegg/
pathway.html) and GenMAPP (http://www.genmapp.org/).
Analysis of hepatic enzyme activities involved in fatty acid
synthesis and β-oxidation
Approximately 1.5 g of each liver was homogenized with
10 ml of 0.25 M sucrose containing 1 mM EDTA and 3 mM
Tris-HCl (pH 7.2) (Expt. 2). The homogenate was centrifuged
at 200,000 × g for 30 min. The activities of enzymes
involved in lipogenesis were measured spectrophoto-
metrically using the supernatant as an enzyme source as
detailed previously [10]. The activities of enzymes related
to β-oxidation were analyzed using the whole liver homoge-
nate as an enzyme source [10].
Statistical analysis
The values were expressed as means ± standard errors
(SE). The data were analyzed with the Kruskal-Wallis test to
detect significant effects of dietary compounds, and the
differences between means at the level of p<0.05 were
evaluated with Dunn’s multiple comparison procedure.Soy Isoflavones and Lipid Metabolism
Vol. 44, No. 3, 2009
225
Results
Growth parameters, and serum isoflavone and lipid concen-
trations
No significant differences were seen in growth, food
intake and liver weight among the groups in either experi-
ment (Table 1). Genistein was detected in the serum of rats
given genistein (Expts. 1 and 2), but not in the animals fed an
isoflavone-free diet or a diet containing daidzein (Table 1).
The concentration of genistein increased dose-dependently
in response to dietary genistein in Expt. 2. Not only daidzein
but also equol was detected in rats fed daidzein (Expt. 1).
In Expt. 1, a diet containing 2 g/kg of genistein compared
to an isoflavone-free diet significantly lowered serum
triacylglycerol levels (Table 1). Although the differences
were not significant, genistein tended to lower cholesterol,
phospholipid, and free fatty acid concentrations (17.3, 20.9
and 25.3% reductions, respectively) in serum. Daidzein
caused a 32.0% reduction in the serum triacylglycerol
concentration, but this was not significant. Daidzein was
ineffective in altering serum concentrations of cholesterol,
phospholipid, and free fatty acid. In Expt. 2, a significant
decrease in serum triacylglycerol concentrations in rats fed a
diet containing 2 g/kg of genistein compared to those fed an
isoflavone-free diet was confirmed. In addition, we observed
that dietary genistein at 2 g/kg significantly lowered serum
concentrations of cholesterol in Expt. 2. Although the
differences were not significant, the levels of serum triacyl-
glycerol and cholesterol tended to be lower in rats given a
diet containing 1 g/kg of genistein than in those fed an
isoflavone-free diet.
Gene expression profile in the liver of rats fed genistein or
daidzein (Expt. 1)
Compared to a diet free of isoflavone, genistein signifi-
cantly caused >1.5-fold changes in the expression of 154
genes and daidzein altered the expression of 38 genes in
liver (Table 2). The genes whose expression was modulated
by genistein and/or daidzein were classified into categories
according to function. Many of the genes affected by
genistein were categorized as a playing role in the metabo-
lism of lipid, carbohydrate, amino acid, and protein, and
other metabolic processes. However, no gene was found in
the category of metabolism in rats given daidzein. Among
the genes classified into the metabolism group, we found
that genistein affected the mRNA expression of many genes
related to lipid and carbohydrate metabolism. Because
analyses of serum lipid indicated that genistein affected lipid
metabolism (Table 1), we picked out the genes associated
with lipid metabolism whose expression was modified more
than 1.5-fold by dietary isoflavones and listed them in
Table 3. Dietary genistein significantly lowered the gene
expression levels of lipogenic enzymes (Me1 and Acyl),
and of a transcription factor (Srebf1) that regulates the
expression of many enzymes involved in fatty acid and
triacylglycerol synthesis [13]. Daidzein-dependent changes
in the expression of these transcripts were not significant.
Acsl4 catalyzes the ligation of a fatty acid and CoA to
produce acyl-CoA with preferential activity for arachidonic
and eicosapentaenoic acids, and plays a role in the regulation
of fatty acid oxidation and triacylglycerol synthesis [14].
Genistein caused a significant increase in the mRNA expres-
sion of Acsl4. The daidzein-evoked change in this parameter
was not significant. The microarray analysis showed that
Table 1. Effect of dietary isoflavones on growth parameters, and levels of serum isoflavones and lipids in rats1
1 Values represent the mean ± SE for 7 rats. Values in the same experiment with different superscripts differ significantly at p<0.05.
2 ND, not detectable.
Dietary isolfavone (Expt. 1) Dietary genistein (g/kg diet) (Expt. 2)
none genistein daidzein 0 1.0 2.0
Body weight gain (g/day) 9.61 ± 0.33 8.28 ± 0.37 9.60 ± 0.19 9.85 ± 0.35 9.30 ± 0.36 8.84 ± 0.20
Food intake (g/day) 20.8 ± 0.8 19.3 ± 0.8 21.4 ± 0.4 23.4 ± 0.8 22.9 ± 0.7 21.6 ± 0.5
Liver (g/100 g body weight) 5.51 ± 0.27 5.44 ± 0.13 6.04 ± 0.15 5.48 ± 0.10 5.32 ± 0.09 5.19 ± 0.09
Serum isoflavones (µmol/l)2
Genistein ND 8.17 ± 0.48 ND ND 6.82 ± 0.41 10.1 ± 1.0
Daidzein ND ND 6.41 ± 0.68 ND ND ND
Equol ND ND 5.48 ± 1.15 ND ND ND
Serum lipids (mmol/l)
Triacylglycerol 3.84 ± 0.61b 2.18 ± 0.29a 2.61 ± 0.32ab 4.57 ± 0.58b 4.17 ± 0.39ab 3.22 ± 0.31a
Cholesterol 2.55 ± 0.04ab 2.11 ± 0.10a 3.09 ± 0.11b 3.15 ± 0.25b 2.58 ± 0.21ab 2.43 ± 0.11a
Phospholipid 2.82 ± 0.21ab 2.23 ± 0.11a 2.99 ± 0.07b 3.04 ± 0.15 2.90 ± 0.18 2.80 ± 0.11
Free fatty acid 1.25 ± 0.25 0.934 ± 0.095 1.21 ± 0.20 1.16 ± 0.110 1.13 ± 0.13 1.15 ± 0.06Y. Takahashi et al.
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genistein also affected the expression of genes related to
lipid transport. Genistein significantly increased the mRNA
level of Cd36, also known as fatty acid translocase, but
decreased that of Sorl1, a member of the LDL receptor gene
family. Daidzein caused similar changes in these lipid
transporters, but was less effective than genistein, and the
changes were not significant in all cases. Dietary genistein,
but not daidzein, significantly reduced the gene expression
of two enzymes participating in cholesterol synthesis
(Hmgcs1 and Sc4mol). We found that genistein significantly
increased the hepatic mRNA level of Akr1d1 related to bile
acid biosynthesis and the metabolism of steroid hormones
[15]. However, the change in this mRNA level obtained with
daidzein was not significant. In addition to Akr1d1, enzymes
(Smp2a, Sult2a2, Hsd3b, Hsd17b2, and Cyp2a1) involved
in the metabolism of steroid hormones were targeted by
isoflavones. Dietary genistein down-regulated the mRNA
expression of Hsd3b, while it up-regulated the expression of
other genes. The changes obtained with daidzein resembled
those observed with genistein, but were considerably
attenuated and insignificant. Genistein but not daidzein
significantly lowered the mRNA level of Pld1 which
catalyzes the conversion of phosphatidylcholine to diacyl-
glycerol [16].
Enzyme activities involved in lipogenesis and β-oxidation in
rats given genistein (Expt. 2)
The observations made in Expt. 1 indicated that genistein
and daidzein affected lipid metabolism differently, with the
former being more competent. We therefore analyzed the
activities of enzymes involved in lipogenesis and β-
oxidation in rats fed diets containing 1 and 2 g/kg of
genistein in the next trial (Expt. 2). Dietary genistein at
2 g/kg significantly reduced the activities of enzymes
participating in lipogenesis including ATP-citrate lyase,
glucose 6-phospate dehydrogenase, 6-phosphogluconate
dehydrogenase, malic enzyme and pyruvate kinase (Table 4).
These activities were also considerably lower in rats fed a
diet containing 1 g/kg of genistein than in those fed an
isoflavone-free diet. However, a significant reduction was
observed in ATP-citrate lyase but not in the other enzymes.
Dietary genistein at 1 and 2 g/kg caused a 15.2 and 21.5%
decrease in the activity of fatty acid synthase, respectively.
However, the reductions were not significant. Diets
containing 1 and 2 g/kg of genistein compared to an
isoflavone-free diet increased the activity of carnitine
palmitoyltransferase, enoyl-CoA hydratase, 3-hydroxyacyl-
CoA dehydrogenase and 3-ketoacyl-CoA thiolase involved
in β-oxidation. The increases were all significant except on
one occasion (carnitine palmitoyltransferase activity in rats
fed 1 g/kg of this isoflavone). The activity levels of these
β-oxidation enzymes were comparable between rats fed 1
and 2 g/kg of genistein. However, dietary genistein failed
to affect the rate of peroxisomal palmitoyl-CoA oxidation
and the activity of acyl-CoA oxidase and 2,4-dienoyl-CoA
reductase.
Table 2. Distribution into functional categories of gene transcripts whose expression was altered more than 1.5-fold by dietary
isoflavones1
1 Numbers of genes for which mRNA expression was significantly different in genistein vs isoflavone-free and daidzein vs isoflavone-
free, respectively (p<0.05).
Functional category
Genistein versus Isoflavone-free Daidzein versus Isoflavone-free
Up Down Up Down
Metabolism
Lipid and carbohydrate metabolism 8 10 0 0
Amino acid and protein metabolism 2 9 0 0
Other metabolism 1 4 0 0
Signal transduction 7 10 0 3
T r a n s c r i p t i o n 34 02
Stress responsive, xenobiotic metabolism and electron 
transport
51 0 6 3
Other transport 2 8 1 0
Cell cycle, apoptosis, and DNA/RNA modification 3 0 3 3
Cell adhesion 2 1 0 4
Other biological function 0 4 0 2
Biological function unknown 4 14 4 2
Expressed sequence tags and unknown genes 21 22 1 4
Total 58 96 15 23Soy Isoflavones and Lipid Metabolism
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Discussion
It has been reported that dietary soy isoflavones exert
hypolipidemic actions in experimental animals [5–10].
However, studies to compare physiological activities of
genistein and daidzein, major isoflavone species in soy, are
scarce. The present study showed that genistein is more
effective than daidzein in lowering serum triacylglycerol
levels and in changing the expression of genes associated
with lipid metabolism in liver.
The microarray analysis showed that the genes involved
in hepatic fatty acid synthesis (Acly, Me1, and Srebf1) were
the targets to be down-regulated by isoflavones (Table 3).
The effect was much stronger with genistein than with
daidzein. Consistent with this observation, dietary genistein
decreased the activities of lipogenic enzymes (Table 4).
Moreover, we observed that genistein increased the acti-
vities of several enzymes related to β-oxidation (Table 4).
Therefore, it is suggested that dietary genistein decreased
serum lipid levels through a reduction in fatty acid synthesis
and an increase in β-oxidation in the liver. However, our
microarray analysis barely detected isoflavone-dependent
changes in mRNA levels of enzymes related to β-oxidation.
None of the gene for enzymes involved in β-oxidation was
up-regulated more than 1.5-fold either by genistein or by
daidzein (Table 3). Detailed examination of the DNA micro-
Table 3. Microarray analyses of genes involved in lipid metabolism whose expression was affected (>1.5-fold) by either genistein or
daidzein1
1 Fold change represents the mean ratio ± SE from each of 5 dependent microarray experiments, comparing genistein and daidzein groups
with an isoflavone-free diet group. Values in a row with different superscripts are significantly different at p<0.05.
GenBank accession no. Gene name Gene 
symbol
Fold change (microarray)
Isoflavone-free Genistein Daidzein
Fatty acid metabolism
M30596 Malic enzyme 1 Me1 1.00 ± 0.07b 0.559 ± 0.128a 1.03 ± 0.10b
NM_016987 ATP citrate lyase Acly 1.00 ± 0.07b 0.532 ± 0.155a 0.758 ± 0.13ab
AF286470 Sterol regulatory element-binding 
factor 1
Srebf1 1.00 ± 0.07b 0.568 ± 0.101a 0.666 ± 0.138ab
NM_053623 Acyl-CoA synthetase long-chain 
family member 4
Acsl4 1.00 ± 0.03a 1.68 ± 0.23b 1.36 ± 0.14ab
Fatty acid transport
NM_031561 Cd36 antigen Cd36 1.00 ± 0.11a 2.89 ± 0.86b 1.29 ± 0.22ab
AF072411 Cd36 antigen Cd36 1.00 ± 0.08a 2.78 ± 0.76b 1.14 ± 0.24ab
AA850618 Sortilin-related receptor, LDLR class 
A repeats-containing
Sorl1 1.00 ± 0.03b 0.359 ± 0.069a 0.757 ± 0.046ab
Cholesterol synthesis
NM_017268 3-hydroxy-3-methylglutaryl-
Coenzyme A synthase 1
Hmgcs1 1.00 ± 0.04b 0.654 ± 0.051a 0.920 ± 0.047ab
NM_080886 Sterol-C4-methyl oxidase-like Sc4mol 1.00 ± 0.13b 0.546 ± 0.031a 0.864 ± 0.063ab
Bile acid and steroid hormone metabolism
D17309 Aldo-keto reductase family 1, 
member D1
Akr1d1 1.00 ± 0.10a 1.86 ± 0.22b 1.44 ± 0.11ab
NM_012695 Rat senescence marker protein 2A 
gene, exons 1 and 2
Smp2a 1.00 ± 1.19a 25.9 ± 8.0b 3.84 ± 1.04ab
D14989 Sulfotransferase family 2A, 
dehydroepiandrosterone (DHEA)-
preferring, member 2
Sult2a2 1.00 ± 0.07a 4.97 ± 3.81b 1.08 ± 0.22a
NM_012584 7-Dehydrocholesterol reductase Hsd3b 1.00 ± 0.12b 0.0837 ± 0.0828a 0.73 ± 0.10ab
NM_024391 Hydroxysteroid (17-beta) 
dehydrogenase 2
Hsd17b2 1.00 ± 0.36a 3.98 ± 1.93b 2.27 ± 0.50ab
NM_012692 Cytochrome P450 IIA1 (hepatic 
steroid hydroxylase IIA1) gene
Cyp2a1 1.00 ± 0.20a 3.10 ± 0.29b 1.30 ± 0.20ab
Glycerolipid metabolism
AB000779 Phospholipase D1 Pld1 1.00 ± 0.04b 0.634 ± 0.063a 0.781 ± 0.048abY. Takahashi et al.
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array results revealed that daidzein caused a significant
1.44-fold increase in the mRNA expression of enoyl-CoA
hydratase/3-hydroxyacyl CoA dehydrogenase (Ehhadh), but
the genistein-dependent change in this parameter (1.33-fold)
was not significant. No other significant isoflavone-
dependent changes were observed in the mRNA expression
of enzymes related to β-oxidation. Genistein-dependent
changes in the activity of enzymes involved in hepatic β-
oxidation were rather small (10.4–41.1%) (Table 4). Given
that the enzyme activity levels parallel the mRNA levels,
the DNA microarray analysis may not be sensitive and
accurate enough to detect these small changes.
The liver is a central organ of cholesterol homeostasis
[17]. It has been reported that dietary isoflavone decreased
cholesterol levels in the liver and serum of rats fed a high-
cholesterol diet, accompanying a marginal increase in the
activity of hepatic cholesterol 7-hydroxylase, the key
enzyme regulating the degradation of cholesterol to bile
acids [9]. In the present study, we observed that serum
cholesterol levels were significantly lower or tended to be
lower in rats fed diets containing genistein than in the
animals fed an isoflavone-free diet (Table 1). As genistein
significantly increased the mRNA level of Akr1d1, but
decreased those of Hmgcs1 and Sc4mol observed in the
microarray analysis (Table 3), enhanced degradation of
cholesterol as well as the decrease in cholesterogenesis
may account for the cholesterol-lowering effect of genistein.
We also found that several genes related to steroid hormone
metabolism were affected by isoflavones. For example,
dietary genistein considerably reduced the mRNA level of
Hsd3b (Table 3), which plays an important role in the
biosynthesis of all classes of hormonal steroids including
androgens and estrogens [18]. Also, Akd1d1 is an enzyme
that affects the first step of the degradation of steroid
hormones [15]. Therefore, it is possible that dietary isofla-
vones also affect hepatic steroid hormone metabolism.
The present study showed that dietary genistein compared
to daidzein was more competent in affecting serum lipid
concentrations and mRNA levels of proteins associated with
lipid metabolism in liver. It has been reported that genistein,
compared with daidzein, has greater affinity for the estrogen
receptors [12] and a stronger inhibitory effect on the activity
of tyrosine kinase [19]. Therefore, it is also possible that
genistein has more influence than daidzein on lipid metabo-
lism. In fact, genistein has been previously demonstrated to
be stronger than daidzein in increasing the gene expression
of apolipoprotein A-I, a major component of high density
lipoprotein, in HepG2 cells [20]. As the gene expression of
apolipoprotein A-I is under the control of estrogen receptor-
alpha [21], this effect is ascribable to the difference between
these isoflavones in affinity for this receptor. Also, it has
been reported that genistein interferes with the activation of
CCAAT/enhancer-binding protein (C/EBP)β by inhibiting
tyrosine-phosphorylation [22]. This results in impairments
of the mRNA expression of peroxisome proliferator-activated
receptor (PPAR)γ and C/EBPα, which promote adipogenesis.
Daidzein with no tyrosine kinase inhibitory activity had
minimal effect on this process.
It has been reported that equol, a metabolite of daidzein, is
stronger than daidzein and similar to genistein in its affinity
Table 4. Effect of dietary genistein on the activities of enzymes involved in hepatic fatty acid synthesis and β-oxidation in rats1
1 Values represent the mean ± SE for 7 rats. Mean values within a row with different superscripts differ significantly at p<0.05.
Dietary genistein (g/kg diet)
0 1.0 2.0
Enzymes involved in fatty acid synthesis (nmol/min per mg protein)
Fatty acid synthase 53.9 ± 6.3 45.7 ± 4.6 42.3 ± 5.8
ATP-citrate lyase 154 ± 11b 109 ± 8a 106 ± 10a
Glucose 6-phospate dehydrogenase 210 ± 22b 149 ± 13ab 137 ± 13a
6-Phosphogluconate dehydrogenase 141 ± 9b 119 ± 9ab 110 ± 8a
Malic enzyme 155 ± 16b 132 ± 5ab 107 ± 10a
Piruvate kinase 656 ± 28b 573 ± 29ab 553 ± 29a
Enzymes involved in β-oxidation (nmol/min per mg protein)
Peroxisomal palmitoyl-CoA oxidation 1.77 ± 0.10 2.05 ± 0.04 2.09 ± 0.17
Acyl-CoA oxidase 1.24 ± 0.05 1.33 ± 0.07 1.37 ± 0.05
Carnitine parmitoyltransferase 2.92 ± 0.21a 3.79 ± 0.19ab 4.12 ± 0.33b
Enoyl-CoA hydratase 6815 ± 207a 7732 ± 208b 7702 ± 210b
3-Hydroxyacyl-CoA dehydrogenase 425 ± 11a 508 ± 22b 503 ± 16b
3-Ketoacyl-CoA thiolase 170 ± 16a 233 ± 15b 238 ± 13b
2,4-Dienoyl-CoA reductase 2.55 ± 0.18 2.98 ± 0.20 3.01 ± 0.10Soy Isoflavones and Lipid Metabolism
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for the estrogen receptors, and is stronger than daidzein and
genistein in its antioxidative activity [11]. So it is possible
that equol also exerts profound effects on lipid metabolism.
In the present study, a considerable amount of equol was
detected in the serum of rats fed daidzein (Table 1). In spite
of this finding, dietary daidzein was weaker than genistein in
influencing lipid metabolism. Therefore, it is unlikely that
equol has strong activity in improving lipid metabolism in
rats. In relation to this, it has been reported that equol is
weaker than genistein or daidzein in activating PPARα and
PPARγ [12].
In the present study, genistein at a dietary level of 2 g/kg
effectively reduced hepatic lipogenesis and serum lipid
levels. Because rats consumed approximately 20 g of the
experimental diets in a day (Table 1), daily consumption of
genistein is estimated to be 40 mg in the animals fed an
experimental diet containing this compound. As one gram of
soybean contains about 1 mg of genistein [23], this value
corresponds to the consumption of approximately 40 g of
soybean in a day. When extrapolated from rats of 300 g body
weight to humans of 60 kg body weight, the amount
becomes 8 kg of soybean per day per person, which is not
achievable. However, it has been reported that considerable
differences exist in the metabolism of isoflavones between
rats and humans. Gu et al. [24] showed that the plasma
genistein concentration was 11-fold higher in women than
in female rats at 4 h after a single administration of this
isoflavone at a dose of 1 mg/kg body weight in the form of
a soy protein isolate. This difference may represent a
consequence of diversity in the absorption, metabolism or
elimination of the isoflavone between humans and rats.
Also, this observation raised the possibility that genistein
exerts its physiological activity in humans at a dose much
lower than that required in rats. This needs to be clarified.
In conclusion, genistein was more effective than daidzein
in lowering serum triacylglycerol levels. The DNA micro-
array analysis revealed that genistein affected mRNA levels
of several genes involved in fatty acid metabolism, and
cholesterol and steroid metabolism in rat liver. The changes
were much weaker with daidzein than genistein for all these
genes. We also showed that genistein decreased the activities
of many lipogenic enzymes, but increased those of enzymes
related to β-oxidation in the liver. These changes may
account for the different effects of genistein and daidzein on
the serum triacylglycerol level.
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